Working with Industry - HCS as Catalysts of Technology Adoption Dr Darren Clark, CEO Medilink East Midlands
UK Life Sciences Reproduced from HM Government’s Strength & Opportunity Report 2011
Regional Strengths Med Tech Companies Reproduced from HM Government’s Strength & Opportunity Report % of all companies + Largest Biotech Cluster in East of England
Common Goal
1 st Challenge: New Product Development Identify customer need Identify solution Translate into product Market to customer Everybody’s Happy Traditional Markets
NPD in Healthcare Clinician Patient Commissioner Trust But who is the customer for health products?
2nd Challenge: Complex Innovation Landscape NICE NIC Researchers Universities Research Councils IMRCs /Catapults Companies Medilinks TSB/BIS CCGs Health Technologies KTN EUCOMEDABHI / BIVDA NHS Trusts/ doctors etc CLAHRC / BRUs/ AHSC / HTCs EU Commission DH/NHS FCO Companies Professional Institutions InternationalRegional NIHR NTAC Medilink UK
Medilink Model Sector Specific Industry association Membership based Not-for-profit Geographical focus Facilitate collaborations:
Medilink UK BioBusiness NI Medilink East Midlands Medilink North West Medilink South West MediWales Medilink West Midlands Medilink Yorkshire & Humber SEHTA BioBusiness NI Medilink East Midlands Medilink North West Medilink South West MediWales Medilink West Midlands Medilink Yorkshire & Humber SEHTA ›1,000 members
Working Together Wealth Health WealthHealth HCS
Contact for Further Information Dr Darren Clark Chief Executive Medilink East Midlands BioCity Nottingham Pennyfoot Street Nottingham NG1 1GF Tel: Fax: web: